van der Waals F W, Mohrs J, Foets M
Women's Health Studies, Medical Faculty, University of Amsterdam, The Netherlands.
BMJ. 1993 Aug 7;307(6900):363-6. doi: 10.1136/bmj.307.6900.363.
To analyse sex differences among recipients of benzodiazepines in Dutch general practice.
Study of consultations and associated interventions as recorded in the Dutch national survey of general practice.
Practices of 45 general practitioners monitored during 1 April to 30 June 1987.
61,249 patients (29,035 (47.4%) men in the age groups 19-44, 45-64, and 65 years and over.
Symptoms among recipients of repeat as well as new benzodiazepine prescriptions stratified by sex and age.
Prescriptions for benzodiazepines were found to be significantly more common among women than among men, (a) after correcting for the sex distribution of the total patient population, and (b) in the two oldest age groups after correcting for the number of consultations. Of all prescriptions for benzodiazepines, 89% (6055/6777) were repeats and 70% (4759/6777) requests. Only 9% (439/4759) of these were authorized by the general practitioner, the rest being issued by the general practitioner's assistant after he or she had referred to the diagnosis in the patient's record. In contrast, only three (1%) of the 492 first time recipients of benzodiazepines had requested a prescription and were not seen by the general practitioner. Women (43/96; 45%) aged 45-64 years received their first prescription for benzodiazepines almost twice as often as men (15/63; 24%) without symptoms or a diagnosis being an indication (female to male relative risk 1.88 (95% confidence interval 1.15 to 3.08)).
The sex difference among first time recipients of benzodiazepines seems to be due to general practitioners being less stringent when prescribing this drug for women. The difference continues in repeat prescriptions, physicians failing to check adequately the need for these.
分析荷兰全科医疗中苯二氮䓬类药物接受者的性别差异。
对荷兰全国全科医疗调查中记录的会诊及相关干预措施进行研究。
1987年4月1日至6月30日期间对45名全科医生的诊疗实践进行监测。
61249名患者(年龄在19 - 44岁、45 - 64岁以及65岁及以上的男性有29035名(占47.4%))。
按性别和年龄分层的重复及新开具苯二氮䓬类药物处方接受者的症状。
(a)在校正总体患者人群的性别分布后,以及(b)在校正会诊次数后,在两个年龄最大的年龄组中,发现女性开具苯二氮䓬类药物的处方显著多于男性。在所有苯二氮䓬类药物处方中,89%(6055/6777)是重复处方,70%(4759/6777)是患者要求开具的。其中只有9%(439/4759)是由全科医生批准的,其余是全科医生助理在参考患者病历中的诊断后开具的。相比之下,492名首次接受苯二氮䓬类药物治疗的患者中只有3名(1%)要求开具处方且未被全科医生诊治。45 - 64岁的女性(43/96;45%)首次开具苯二氮䓬类药物处方的频率几乎是男性(15/63;24%)的两倍,且没有症状或诊断作为指征(女性与男性的相对风险为1.88(95%置信区间为1.15至3.08))。
首次接受苯二氮䓬类药物治疗者的性别差异似乎是由于全科医生在为女性开此药时要求不那么严格。这种差异在重复处方中依然存在,医生没有充分检查这些处方的必要性。